BRPI0812966A2 - formulações de n-(2-acetil-4,6-dimetilfenil)-3-{[(3,4 dimetil-5-isoxazolil)amino]sulfonil}-2-tiofenocarboxamida - Google Patents

formulações de n-(2-acetil-4,6-dimetilfenil)-3-{[(3,4 dimetil-5-isoxazolil)amino]sulfonil}-2-tiofenocarboxamida

Info

Publication number
BRPI0812966A2
BRPI0812966A2 BRPI0812966A BRPI0812966A BRPI0812966A2 BR PI0812966 A2 BRPI0812966 A2 BR PI0812966A2 BR PI0812966 A BRPI0812966 A BR PI0812966A BR PI0812966 A BRPI0812966 A BR PI0812966A BR PI0812966 A2 BRPI0812966 A2 BR PI0812966A2
Authority
BR
Brazil
Prior art keywords
thiophenecarboxamide
dimethylphenyl
isoxazolyl
sulfonyl
acetyl
Prior art date
Application number
BRPI0812966A
Other languages
English (en)
Inventor
Schoeneman Aaron
Trammel Andrew
Chen Jinling
Amsberry Kent
Rajewski Lian
Original Assignee
Encysive Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Encysive Pharmaceuticals Inc filed Critical Encysive Pharmaceuticals Inc
Publication of BRPI0812966A2 publication Critical patent/BRPI0812966A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BRPI0812966A 2007-06-25 2008-06-24 formulações de n-(2-acetil-4,6-dimetilfenil)-3-{[(3,4 dimetil-5-isoxazolil)amino]sulfonil}-2-tiofenocarboxamida BRPI0812966A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93721507P 2007-06-25 2007-06-25
PCT/US2008/007836 WO2009002490A2 (en) 2007-06-25 2008-06-24 Formulations of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide

Publications (1)

Publication Number Publication Date
BRPI0812966A2 true BRPI0812966A2 (pt) 2017-05-16

Family

ID=39720482

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0812966A BRPI0812966A2 (pt) 2007-06-25 2008-06-24 formulações de n-(2-acetil-4,6-dimetilfenil)-3-{[(3,4 dimetil-5-isoxazolil)amino]sulfonil}-2-tiofenocarboxamida

Country Status (12)

Country Link
US (1) US20080317858A1 (pt)
EP (1) EP2170278A2 (pt)
JP (1) JP2010531357A (pt)
KR (1) KR20100032863A (pt)
CN (1) CN102137655A (pt)
AU (1) AU2008269149A1 (pt)
BR (1) BRPI0812966A2 (pt)
CA (1) CA2689048A1 (pt)
IL (1) IL202513A0 (pt)
MX (1) MX2009013022A (pt)
RU (1) RU2009146836A (pt)
WO (1) WO2009002490A2 (pt)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
MXPA02006461A (es) * 1999-12-31 2003-09-05 Texas Biotechnology Corp Sulfonamidas y derivados de las mismas que modulan la actividad de endotelina.
AU2001282886A1 (en) * 2000-07-13 2002-01-30 Pharmacia Corporation Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
US20030198666A1 (en) * 2002-01-07 2003-10-23 Richat Abbas Oral insulin therapy
BRPI0715174A2 (pt) * 2006-08-04 2015-03-24 Encysive Pharmaceuticals Inc Polimorfos de n-(2-acetil-4,6-dimetilfenil)-2-{[(3,4-dimetil-5-isoxazolil) -amino]sulfonil}-2-tiofenocarboxamida
US20080145433A1 (en) * 2006-11-09 2008-06-19 Gilead Colorado, Inc. Darusentan oral dosage form

Also Published As

Publication number Publication date
KR20100032863A (ko) 2010-03-26
AU2008269149A1 (en) 2008-12-31
MX2009013022A (es) 2010-01-20
CA2689048A1 (en) 2008-12-31
RU2009146836A (ru) 2011-07-27
IL202513A0 (en) 2010-06-30
WO2009002490A3 (en) 2010-04-08
CN102137655A (zh) 2011-07-27
EP2170278A2 (en) 2010-04-07
US20080317858A1 (en) 2008-12-25
JP2010531357A (ja) 2010-09-24
WO2009002490A2 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
EA200802008A1 (ru) Фармацевтические композиции
ATE527244T1 (de) N-(1,1,1,3,3,3-hexafluor-2-hydroxypropan-2- yl)benzyl-n'-arylcarbonylpiperazinderivate als lxr modulatoren
NO20075628L (no) Farmasøytiske formuleringer
BRPI0511900A (pt) composições farmacêuticas
SI1998783T1 (sl) Oftalmični sestavki, ki obsegajo providon-jod
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
BRPI0714539A2 (pt) "formas farmacêuticas"
DK1811959T4 (da) Oftalmiske sammensætninger
DK1753434T3 (da) Forbedret ophthalmisk bimatoprost-oplösning
EP1903866A4 (en) IMPROVED RELEASE OF TETRAHYDROCANNABINOL
DK1931702T3 (da) Silkeproteiner
DE602006011637D1 (de) N-(hetero)aryl-indolderivate als pestizide
DK1947935T3 (da) Flydende sulfonylurinstofherbicidformuleringer
BRPI0719275A2 (pt) Composições de carbamatos de fenil-alquil-amino
EP1796719A4 (en) REFRIGERANT TEMPERATURE STABLE FLUID COMPOSITION COMPOSITIONS
EP1858914A4 (en) NETWORKS OF PEPTIDES
BRPI0715174A2 (pt) Polimorfos de n-(2-acetil-4,6-dimetilfenil)-2-{[(3,4-dimetil-5-isoxazolil) -amino]sulfonil}-2-tiofenocarboxamida
BRPI0913709A2 (pt) "formulação farmacêutica"
BRPI0812966A2 (pt) formulações de n-(2-acetil-4,6-dimetilfenil)-3-{[(3,4 dimetil-5-isoxazolil)amino]sulfonil}-2-tiofenocarboxamida
NO20055220D0 (no) Avskjaetingslodd for vegmast
PL2069323T3 (pl) Sposób otrzymywania N-(2-acetylo-4,6-dimetylofenylo)-3-{[(3,4-dimetylo-5-izoksazolilo)amino]sulfonylo}-2-tiofenokarboksyamidu
DK2069323T3 (da) Fremgangsmåder til fremstillingen af N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4-dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophencarboxamid
ATE387189T1 (de) Sprühgetrocknete pharmazeutische zusammensetzungen
ITPD20050018A1 (it) Composizione insetticida
UA11937S (uk) Кашкет чоловічий формений

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]